KCM
AVNS

Kennedy Capital Management’s Avanos Medical AVNS Stock Holding History

Kennedy Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-28,728
Closed -$572K – 691
2024
Q2 		$572K Sell
28,728
-124
-0.4% -$2.42K 0.01% 633
2024
Q1 		$574K Sell
28,852
-430
-1% -$8.31K 0.01% 649
2023
Q4 		$657K Sell
29,282
-464
-2% -$9.58K 0.01% 619
2023
Q3 		$601K Hold
29,746
– – 0.01% 602
2023
Q2 		$760K Hold
29,746
– – 0.02% 573
2023
Q1 		$885K Buy
+29,746
New +$864K 0.03% 501

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Kennedy Capital Management's AVNS Position: Q3 2024 in Review

Kennedy Capital Management sold out of Avanos Medical (AVNS) in Q3 2024, closing a stake of 28,728 shares — an estimated $572K sold.

Kennedy Capital Management first reported a position in AVNS in Q1 2023 and held it in 6 quarters. The position peaked at $885K in Q1 2023. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

  • Kennedy Capital Management reported no remaining Avanos Medical position as of Q3 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 28,728 Avanos Medical shares in Q3 2024, an estimated $572K.
  • Kennedy Capital Management first reported a position in Avanos Medical in Q1 2023 and held it in 6 quarters.
  • Kennedy Capital Management's Avanos Medical position peaked at $885K in Q1 2023.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on Kennedy Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.